Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Measurement of medroxyprogesterone acetate (Provera ) by radioimmunoassay.

× No keyword cloud information.

11 in total

Review 1. Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors: P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal: Clin Pharmacokinet Date: 1992-05 Impact factor: 6.447

Review 2. Controlled-release delivery systems for hormones. A review of their properties and current therapeutic use.

Authors: L R Beck; V Z Pope
Journal: Drugs Date: 1984-06 Impact factor: 9.546

3. Comparative pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular routes.

Authors: M Salimtschik; H T Mouridsen; J Loeber; E Johansson
Journal: Cancer Chemother Pharmacol Date: 1980 Impact factor: 3.333

Review 4. Long acting contraceptives. Present status.

Authors: G Benagiano; F M Primiero
Journal: Drugs Date: 1983-06 Impact factor: 9.546

5. Medroxyprogesterone acetate (MAP) plasma levels after multiple high-dose administration in advanced cancer patients.

Authors: C M Camaggi; E Strocchi; M Giovannini; B Angelelli; B Costanti; E Zebini; P Ferrari; F Pannuti
Journal: Cancer Chemother Pharmacol Date: 1983 Impact factor: 3.333

6. Radioimmunoassays of ethinyl-norgestrienone (R-2323) and medroxyprogesterone acetate (MPA) and their clinical applicability.

Authors: J Frick; G Bartsch; G Jakse
Journal: Urol Res Date: 1977

7. Medroxyprogesterone acetate: steady-state pharmacokinetics bioequivalence of two oral formulations.

Authors: K Pollow; R Kreienberg; N Di Pietro
Journal: J Cancer Res Clin Oncol Date: 1989 Impact factor: 4.553

8. Oral high-dose medroxyprogesterone acetate (MAP) in treatment of advanced breast cancer. A preliminary report of clinical and experimental studies.

Authors: M Izuo; Y Iino; K Endo
Journal: Breast Cancer Res Treat Date: 1981 Impact factor: 4.872

9. The pharmacokinetics of high-dose medroxyprogesterone acetate (MPA) in the therapy of advanced breast cancer.

Authors: H C Blossey; H H Bartsch; D Kanne; J Koebberling; G A Nagel
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

10. Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology.

Authors: V Tamassia; A Battaglia; F Ganzina; A M Isetta; G Sacchetti; F Cavalli; A Goldhirsch; K Brunner; G Bernardo; G Robustelli della Cuna
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333